Chemotherapy At Home Services Global Market Report 2024

The chemotherapy at-home services market size has grown rapidly in recent years. It will grow from $1.58 billion in 2023 to $1.75 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to the increased incidence of cancer, growing patient demand for receiving care at home, hospital capacity constraints, improved home healthcare infrastructure, and supportive government policies.

The chemotherapy at-home services market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to rising healthcare costs, an aging population, the expansion of home healthcare services, an increased focus on patient-centric care, and the need to reduce inpatient stays and manage chronic diseases. Major trends in the forecast period include the integration of AI and machine learning, personalized medicine approaches, wearable health technology, the growth of specialty home infusion services, and collaborative healthcare models.

The rising prevalence of cancer is poised to drive the growth of the chemotherapy-at-home services market in the future. Cancer is characterized by the uncontrolled growth and spread of abnormal cells in the body. Several factors contribute to the increased prevalence of cancer, including aging populations, lifestyle changes, environmental exposures, genetic predispositions, and improved detection through advanced diagnostic techniques. Chemotherapy at-home services enable cancer patients to receive treatment in their own homes, enhancing convenience and quality of life. For example, in 2021, according to the American Cancer Society, there were an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer-related deaths in the United States, marking an increase from 1.8 million new cancer cases and 606,520 deaths reported in 2020. Hence, the growing prevalence of cancer is propelling the growth of chemotherapy at-home services.

Companies in the chemotherapy-at-home services market are offering innovative solutions to revolutionize chemotherapy delivery and improve patient safety and convenience. Chemotherapy care services involve delivering chemotherapy treatment in patients' homes for added comfort and ease. For instance, in September 2022, Jivika Healthcare, an India-based mobile medical service provider, introduced ChemoAtHome, a chemotherapy care service for cancer patients. This service provides safe and high-quality cancer care administered by trained nurses under an MBBS doctor's supervision, with hospital-like setups established at patients' residences. ChemoAtHome aims to offer convenience and cost savings, with potential savings of 20% to 25% on chemotherapy hospital bills. The service includes pre and post-chemotherapy support, such as virtual consultations with oncologists and home-delivered medications.

In August 2022, Walgreens, a US-based drugstore corporation, acquired a majority stake in CareCentrix for an undisclosed sum. This strategic move enables Walgreens to expand its healthcare services and deliver coordinated care to patients in their homes. CareCentrix, a US-based company, provides value-based home solutions to payors and health systems, including home-based chemotherapy infusions that benefit all stakeholders involved.

Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc, Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd, Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare.

North America was the largest region in the chemotherapy at-home services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chemotherapy at home services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Chemotherapy at-home services are an outpatient care option provided by a team of doctors and nurses, allowing cancer patients to receive their treatments at home. These services offer cancer patients the convenience of receiving chemotherapy treatments in the comfort of their own homes instead of in traditional clinical settings such as hospitals or specialized treatment centers.

The products included in chemotherapy at-home services are chemotherapy drugs and chemotherapy infusion pumps. Chemotherapy drugs are medications used to treat cancer by targeting and destroying cancer cells and can be administered orally or intravenously. These services are provided for applications such as breast cancer, blood cancer, ovarian cancer, and colorectal cancer.

The chemotherapy at home services market research report is one of a series of new reports that provides chemotherapy at home services market statistics, including the chemotherapy at home services industry global market size, regional shares, competitors with chemotherapy at home services market share, detailed chemotherapy at home services market segments, market trends, and opportunities, and any further data you may need to thrive in the chemotherapy at home services industry. These chemotherapy at home services market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chemotherapy-at-home services market consists of revenues earned by entities by providing services such as telehealth support, and drug delivery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The chemotherapy-at-home services market also includes sales of portable infusion pumps, chemotherapy drug kits, and home care medical supplies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.